Search

Now showing items 1-10 of 21

DETECTION OF NON-OVARIAN CANCERS ON PHASE 2 OF THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UKFOCSS)

Philpott, S; Rizzuto, I; Fraser, L; Manchanda, R; Hadwin, R; Burnell, M; Mackay, S; Skates, S; Menon, U; Jacobs, I;... (2013-10)

Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population

Blyuss, O; Burnell, M; Ryan, A; Gentry-Maharaj, A; Marino, IP; Kalsi, J; Manchanda, R; Timms, JF; Parmar, M; Skates, SJ;... (2018-10-01)

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History-Based Testing

Manchanda, R; Legood, R; Burnell, M; McGuire, A; Raikou, M; Loggenberg, K; Wardle, J; Sanderson, S; Gessler, S; Side, L;... (2015-01)

Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population

Manchanda, R; Blyuss, O; Gaba, F; Gordeev, VS; Jacobs, C; Burnell, M; Gan, C; Taylor, R; Turnbull, C; Legood, R;... (2018-08)

Should Opportunistic Bilateral Salpingectomy (OBS) for Prevention of Ovarian Cancer Be Incorporated Into Routine Care or Offered in the Context of a Clinical Trial?

Manchanda, R; Chandrasekaran, D; Saridogan, E; Burnell, M; Crawford, R; Brockbank, E; Kalsi, J; Jurkovic, D; Menon, U (2016-01)

Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations

Manchanda, R; Burnell, M; Loggenberg, K; Desai, R; Wardle, J; Sanderson, SC; Gessler, S; Side, L; Balogun, N; Kumar, A;... (2016-07)

Evidence of Stage Shift in Women Diagnosed with Ovarian Cancer during Phase II of the United Kingdom Familial Ovarian Cancer Screening Study

Rosenthal, AN; Fraser, LSM; Philpott, S; Manchanda, R; Burnell, M; Badman, P; Hadwin, R; Rizzuto, I; Benjamin, E; Singh, N;... (2017-06-01)

Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled Trial

Manchanda, R; Loggenberg, K; Sanderson, S; Burnell, M; Wardle, J; Gessler, S; Side, L; Balogun, N; Desai, R; Kumar, A;... (2015-01)

Benchmarking of surgical complications in gynaecological oncology: prospective multicentre study.

Burnell, M; Iyer, R; Gentry-Maharaj, A; Nordin, A; Liston, R; Manchanda, R; Das, N; Gornall, R; Beardmore-Gray, A; Hillaby, K;... (2016-12)

OBJECTIVE: To explore the impact of risk-adjustment on surgical complication rates (CRs) for benchmarking gynaecological oncology centres. DESIGN: Prospective cohort study. SETTING: Ten UK accredited gynaecological oncology ...

Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening.

Fourkala, EO; Gentry-Maharaj, A; Burnell, M; Ryan, A; Manchanda, R; Dawnay, A; Jacobs, I; Widschwendter, M; Menon, U (2012-06-05)

BACKGROUND: In research studies, accurate information of cancer diagnosis is crucial. In women with breast cancer (BC), we compare cancer registration (CR) in England/Wales and self-reporting with independent confirmation. ...